Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Palisade Bio (PALI) Net Margin (2016 - 2023)

Palisade Bio has reported Net Margin over the past 11 years, most recently at 936.0% for Q1 2023.

  • Quarterly Net Margin changed N/A to 936.0% in Q1 2023 from the year-ago period, while the trailing twelve-month figure was 5070.8% through Dec 2023, changed N/A year-over-year, with the annual reading at 5234.0% for FY2023, N/A changed from the prior year.
  • Net Margin was 936.0% for Q1 2023 at Palisade Bio, up from 169760.0% in the prior quarter.
  • Over five years, Net Margin peaked at 936.0% in Q1 2023 and troughed at 169760.0% in Q4 2020.
  • The 3-year median for Net Margin is 74040.0% (2020), against an average of 71345.21%.
  • The largest YoY upside for Net Margin was 6429700bps in 2020 against a maximum downside of -8478356bps in 2020.
  • A 3-year view of Net Margin shows it stood at 84976.44% in 2019, then tumbled by -100bps to 169760.0% in 2020, then surged by 99bps to 936.0% in 2023.
  • Per Business Quant, the three most recent readings for PALI's Net Margin are 936.0% (Q1 2023), 169760.0% (Q4 2020), and 73720.0% (Q3 2020).